• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

House Report Blames Strict FDA for Drug Scarcity


Overly stringent enforcement by health regulators has caused the majority of drug shortages in the United States, according to a new report from a Republican-led House of Representatives committee.

The House Committee on Oversight and Government Reform said U.S. Food and Drug Administration inspections have forced four top generic drugmakers to shut down 30 percent of their manufacturing capacity, throwing the nation's drug supply into disarray.

Responding to the report, the FDA said preventing drug shortages is a "top priority," and that it works with companies to address serious quality issues and minimize supply disruptions.

Read the full story:


Source: Reuters

Related Videos
Dr Michael Morse, Duke University
Joseph Zabinski, PhD, MEM, vice president, head of commercial strategy and AI, OM1
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Video 10 - "Bronchiectasis Exacerbation Management"
Ross Margulies, health care attorney and partner at Foley Hoag LLP.
Pat Van Burkleo
dr robert sidbury
video 10  - "Developing Practical Solutions to Improve Cardiovascular Care"
video 10  - "Developing Practical Solutions to Improve Cardiovascular Care"
Related Content
© 2024 MJH Life Sciences
All rights reserved.